Product Information
MODAFINIL 200 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.3436 per EA under NDC 60505252701. Its NADAC has been published 378 times since Apr 16, 2014.
FDA first approved this application on Feb 3, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the modafinil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Apotex Corp.NDC
60505252701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MODAFINILApproval Type
Generic (ANDA)
FDA Application
ANDA077667FDA Approved
2/3/2014
TE Code
AB
On Market Since
2/3/2014
Pharmacological Classes
Price Statistics
The NADAC for MODAFINIL 200 MG TABLET has been published 378 times since Apr 16, 2014, and over the history we have for it it has declined 97.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3436 per EA |
|---|---|
| All-time high | $12.3451 (Apr 16, 2014) |
| All-time low | $0.2911 (Nov 20, 2024) |
| 52-week high | $0.4092 |
| 52-week low | $0.3436 |
| Median price | $1.4505 |
| Average price | $3.1293 |
| Largest weekly change | -60.0% (May 22, 2024) |
| Weeks tracked | 378 |
| Tracking since | Apr 16, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
modafinil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sympathomimetic-like Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MODAFINIL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MODAFINIL 200 MG TABLET, manufactured by Apotex Corp., is $0.3436 per EA (NDC 60505252701), effective Sep 30, 2026.
How has the price of MODAFINIL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for MODAFINIL 200 MG TABLET has declined 97.2%. It has been tracked across 378 weekly CMS publications since Apr 16, 2014.
What are the highest and lowest recorded NADAC prices for MODAFINIL 200 MG TABLET?
Since Apr 16, 2014, the NADAC for MODAFINIL 200 MG TABLET has ranged from a low of $0.2911 (Nov 20, 2024) to a high of $12.3451 (Apr 16, 2014), with a median of $1.4505 per EA.
Are there cheaper alternatives to MODAFINIL 200 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MODAFINIL 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MODAFINIL 200 MG TABLET?
MODAFINIL 200 MG TABLET (NDC 60505252701) is labeled by Apotex Corp., and CMS classifies it as a generic product.